WebApr 14, 2024 · Finally, Mackenzie Financial Corp bought a new position in CytomX Therapeutics during the first quarter worth $35,000. 70.14% of the stock is owned by institutional investors and hedge funds. WebCompany Type For Profit. Phone Number 6503510353. CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. …
CytomX Raises $70 Million in Series D Financing
WebApr 13, 2024 · Get a real-time CytomX Therapeutics, Inc. (CTMX) stock price quote with breaking news, financials, statistics, charts and more. ... Financial Performance. In 2024, CTMX's revenue was $53.16 million, an increase of 42.48% compared to the previous year's $37.31 million. Losses were -$99.32 million, -14.29% less than in 2024. WebApr 10, 2024 · CytomX Therapeutics has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500. Comparatively, Stoke Therapeutics has a beta of 0.41, meaning that its stock price is 59 ... early voting locations by zip code broward
CytomX Raises $70 Million in Series D Financing - PR …
WebApr 14, 2024 · UBS Group AG grew its stake in CytomX Therapeutics by 322.8% during the third quarter. UBS Group AG now owns 17,793 shares of the biotechnology company's stock worth $26,000 after buying an additional 13,585 shares during the period. Magnus Financial Group LLC bought a new position in CytomX Therapeutics in the 3rd quarter … WebApr 14, 2024 · Synchrony Financial stock opened at $29.77 on Thursday. Synchrony Financial has a 52-week low of $27.15 and a 52-week high of $41.88. The firm has a fifty day moving average of $32.45 and a 200 ... WebApr 14, 2024 · Mackenzie Financial Corp purchased a new stake in CytomX Therapeutics during the first quarter valued at about $35,000. Finally, BNP Paribas Arbitrage SA lifted … early voting locations by zip code ar